General Information
Conference President
Dace Rezeberga (LV)
Vice-presidents
Gilbert GG Donders (B)
Steven Witkin (USA)
Local Organising Committee
Dace Matule (LV)
Ludmila Viksna (LV)
Scientific Committee Members
A. H. Adriaanse (The Netherlands), D. Petrevich (Austria), S. Gerber (Switzerland),
S. Guaschino (Italy), P. G. Larsson (Sweden), J. Martinez de Oliveira (Portugal),
W. Mendling (Germany), P. Judlin (France), J. Paavonen (Finland),
D. Rezeberga (Latvia), B. Stray-Pedersen (Norway), I. Sziller (Hungary),
A. Ugwumadu (UK), C. Ünlü (Turkey)
WORKSHOP ON MANAGEMENT OF VULVOVAGINITIS
Endorsed by ESIDOG, ISIDOG, IUSTI and EBCOG
W. Mendling / P.-G. Larsson / P. Heckzko / G.Donders
29 October 2015
Limited participants
Pre-conference registration necessary
PROGRAMME
| Date | Topic |
|---|---|
| 29 October 2015 | Pre-conference meeting (in Latvian) – Meeting Country Managers ESIDOG/ISIDOG Opening lecture and Ceremony |
| 30 October 2015 | Infections in pregnancy Biomarkers of chorioamnionitis: Is amnioscentesis necessary? A. Ugwumadu (UK) GBS vaccination: Where do we stand? K Slobod (USA) How intensive should we screen for Toxoplasmosis and CMV? B. Stray-Pedersen (N) Debate: Sense of use of antibiotics and probiotics, R. Lamont (UK) and U. Hoyme (D) Sexually Transmitted Infections Resistant Trichomonas: A ghost or a devil? N. Crucizi (B) Is Chlamydia being over-emphasized? P. Horner (UK) Responsible use of antibiotics New antimicrobials: What is in the pipeline? J. Paavonen (FIN) |
| 31 October 2015 | Vulvovaginitis Asymptomatic BV: Does it exist? P.–G. Larsson (S) (Over) use of molecular biology, G. Donders (B) Towards defining probiotics as a drug, Palmera (P) Can Candida be fearsome in pregnancy? L. Petrevic (A) Advanced Course on Vulvovaginitis Management (Meet the experts)* HPV Influence of HPV vaccination on medical consumption, P. Nimienem (FIN) Contamination and Non-sexual transmission of HPV, K. Louvanto (CAN) Biomarkers to predict HPV related cancer, C. Meijer (NL) Time to screen with viral tests, but which test? M. Arbyn (B) |
| 1 November 2015 | Unresolved Clinical Issues G. Donders (B), Frieze (D), P. Greenhouse (UK), P. Heckzko (PL), W. Mendling (D), J. Paavonen (FIN), H. Verstraelen (B) HPV vaccination in older women? Should we screen pregnant women for CMV? The use of vaginal culture? Vulvodynia: vestibulectomy or not? Cytolytic vaginosis, a separate entity? |
Impressions from Riga (Members only)
This content is locked
Login To Unlock The Content!
